[Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
März
Winfried
W
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008019:Life Style; D024821:Metabolic Syndrome / Q000097:blood; D009525:Niacin / Q000008:administration & dosage / Q000627:therapeutic use*; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D014280:Triglycerides; D009525:Niacin; D015248:Gemfibrozil